Antidote is a digital health company on a mission to accelerate the breakthroughs of new treatments by bridging the gap between medical research and the people who need them. 
Antidote was launched as TrialReach in 2010 and rebranded to Antidote in 2016. We're based in the U.S. and London, U.K.
London, GB
Size (employees)
69 (est)+7%
Antidote was founded in 2009 and is headquartered in London, GB
Report incorrect company information

Key People/Management at Antidote

Pablo Graiver

Pablo Graiver

Co-Founder & CEO
Keith Lovell

Keith Lovell

Show more

Antidote Office Locations

Antidote has offices in London, New York and Carmel
London, GB (HQ)
39 Earlham St
Carmel, US
200 S Rangeline Rd
New York, US
205 E 42nd St
Show all (3)
Report incorrect company information

Antidote Financials and Metrics

Summary Metrics

Founding Date


Antidote total Funding

$17.9 m

Antidote latest funding size

$13.50 m

Time since last funding

3 years ago

Antidote investors

Antidote's latest funding round in February 2015 was reported to be $13.5 m. In total, Antidote has raised $17.9 m
Show all financial metrics

Antidote Revenue

Embed Graph
Antidote's revenue was reported to be £2.41 m in FY, 2016

Revenue (FY, 2016)

2.4 m

Gross profit (FY, 2016)

1.3 m

Gross profit margin (FY, 2016), %


Net income (FY, 2016)

(3.3 m)

EBITDA (FY, 2016)

(3.6 m)

EBIT (FY, 2016)

(3.7 m)

Cash (31-Dec-2016)

2.3 m
GBPFY, 2015FY, 2016


2.2 m2.4 m

Cost of goods sold

912.3 k1.1 m

Gross profit

1.3 m1.3 m

Gross profit Margin, %

GBPFY, 2012FY, 2013FY, 2014FY, 2015FY, 2016


284.3 k1.9 m147.5 k1.3 m2.3 m

Accounts Receivable

73.1 k211.4 k504.2 k647.1 k967.5 k

Current Assets

357.4 k2.1 m651.8 k2.2 m3.7 m


1.5 k6.7 k14.9 k85.5 k77 k
GBPFY, 2015FY, 2016

Net Income

(2.2 m)(3.3 m)
GBPY, 2016


46.2 k

Financial Leverage

1.2 x
Show all financial metrics
Report incorrect company information

Antidote Online and Social Media Presence

Embed Graph
Report incorrect company information

Antidote News and Updates

Dunhill’s Antidote to Streetwear

At times the collection seemed to be a bit stiff, but all in all, there was substance to this show.

Opioid Overdose Antidote Naloxone’s Recall Is the Latest Black Eye for Pfizer Unit Hospira

Pfizer's Hospira arm has been at the heart of multiple supply chain breakdowns.

The Philippines Plans a Green ‘Smart City’ as an Antidote to Manila’s Traffic and Pollution

New Clark City is being planned as a twin city to congested Manila.

There’s nothing else like Michael Wolff’s “Fire and Fury”

Fire and Fury, Michael Wolff’s inside account of Donald Trump’s first nine months as US president, is so incendiary it’s become a publishing phenomenon. Quartz…

Global Antidote Market 2018 Key Players, Supply, Consumption, Demand, Growth, Application, Analysis and Forecast to 2022 adds “Antidote Market 2018 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2022”reports to its database. Posted via Industry Today. Follow us on Twitter @IndustryToday

Future Growth in Antidote Market 2018: Boehringer Ingelheim, AstraZeneca, Novartis

HTF MI presents an in-depth assessment of current Antidote key market drivers, market size and trends and Global Antidote opportunities, challenges, and restraints as well as key market segments, technological updates, impact of any regulatory policies as well as key market segments. The research st…
Show more
Report incorrect company information

Antidote Company Life and Culture

Report incorrect company information